Pharmaceutics (ISSN: 1999-4923) is proud to announce its role as a sponsor for the 13th International Dendrimer Symposium (IDS13). This sponsorship highlights the journal’s commitment to supporting the scholarly community and engaging in critical industry discussions with the public.

Time: 30 September–2 October 2026
Place: Stockholm, Sweden
Website: https://ids13.se/
Contact: conference-ids13@kth.se
Early-Bird Registration Deadline: 31 March 2026

The IDS13 scientific program is designed to showcase the diversity of dendritic polymers. Seven thematic areas, spanning synthesis, structure, therapeutics, antimicrobial systems, photo-responsive materials, commercialization, and emerging horizons, will ensure comprehensive coverage across the entire dendritic spectrum.

World-Class Plenary and Invited Speakers

IDS13 boasts an internationally renowned lineup of confirmed speakers—pioneers and leading experts in dendrimer chemistry, nanomedicine, supramolecular science, regenerative medicine, and functional materials—hailing from the USA, France, Japan, China, Spain, Norway, Singapore, Poland, the Netherlands, Portugal, Italy, Taiwan, Turkey, Denmark, and more. Highlights include plenary lectures from the following:

• Prof. D. A. Tomalia (USA, Dendrimer Chemistry);
• Prof. V. Percec (USA, Supramolecules);
• Prof. J-P Majoral (France, Dendrimer Chemistry);
• Prof. K. Rangaramanujam (USA, Nanomedicine).

And many other distinguished scientists in the field (full speaker list available on the official website).

About the Media Partner: Pharmaceutics

Pharmaceutics (ISSN: 1999-4923; IF: 5.5) is a leading international peer-reviewed open access journal published by MDPI, dedicated to all aspects of pharmaceutical sciences, including drug delivery systems, nanomedicine, pharmaceutical materials, and biopharmaceutics. As the media partner for IDS13, Pharmaceutics will feature symposium highlights, research spotlights, and author opportunities for attendees, connecting the dendrimer research community with the broader pharmaceutical science field.

Dendrimers stand at the forefront of next-generation nanomaterials, with transformative potential for precision drug delivery, cancer immunotherapy, regenerative medicine, diagnostics, and sustainable high-performance materials. IDS13 is your opportunity to be part of this global conversation, share your research, and collaborate with the brightest minds in the field to advance dendritic science for the benefit of medicine, materials, and society.